# DAP Pharmaceuticals, LLC – FDA Inspection, Sep 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/dap-pharmaceuticals-llc/422a5631-ac36-485d-923a-fb1b489480a7
Source feed: FDA_Inspections

> FDA inspection 1101800 of DAP Pharmaceuticals, LLC, September 11, 2019. Classification: Official Action Indicated (OAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101800
- Company Name: DAP Pharmaceuticals, LLC
- Inspection Date: 2019-09-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)
- [Investigator](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)

Company: https://www.keypedia.com/companies/dap-pharmaceuticals-llc/65553b5e-2309-4fa7-ac1d-add6cda686fc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
